Byotrol PLC Result of Open Offer (3659P)
August 31 2017 - 1:00AM
UK Regulatory
TIDMBYOT
RNS Number : 3659P
Byotrol PLC
31 August 2017
31 August, 2017
Byotrol Plc
("Byotrol" or the "Company")
Result of Open Offer
On 3 August 2017, Byotrol announced details of a Placing,
Subscription and Open Offer to raise gross proceeds of
approximately GBP4.3 million through the issue of 106,787,000 New
Ordinary Shares at a price of 4 pence per share, with 103,787,000
shares subject to the Placing and 3,000,000 shares subject to the
Subscription. In addition, a further 26,805,156 shares were made
available through the Open Offer.
The Open Offer closed for acceptances at 11.00 a.m. on 30 August
2017. Byotrol is pleased to announce that it has received valid
applications under the Open Offer, including those received under
the Excess Application Facility, in respect of 17,140,787 Open
Offer Shares from Qualifying Shareholders. This represents
approximately 64 per cent. of the Open Offer Shares. Qualifying
Shareholders who have validly applied for Open Offer Shares and
Excess Shares will receive their application in full.
The Placing, Subscription and Open Offer remain conditional,
inter alia, upon the Resolutions being passed at the General
Meeting to be held at 11.00 a.m. on 4 September 2017 and Admission.
Byotrol expects to announce the results of the General Meeting as
soon as practicable on 4 September 2017 after the meeting
concludes. It is expected that Admission will become effective on 5
September 2017.
Capitalised terms not otherwise defined in the text of this
announcement have the meanings given to them in the Company's
circular dated 3 August 2017.
Enquiries:
Byotrol plc 01925 742 000
David Traynor - Chief Executive
finnCap Ltd 020 7220 0500
(Nominated Adviser & Broker)
Geoff Nash/Carl Holmes/James Thompson - Corporate Finance
The information communicated in this announcement contains
inside information for the purposes of Article 7 of the Market
Abuse Regulation (EU) No. 596/2014.
Notes to Editors:
Byotrol plc (BYOT.L), quoted on AIM, is a specialist developer
of residual antimicrobial technologies, identifying, developing,
formulating and commercialising cutting-edge antimicrobial
solutions.
Our patented suite of technologies deliver powerful
broad-spectrum efficacy with residual performance optimised against
commonly occurring and industry-specific pathogens
Founded in 2005, the Company has developed the technology that
creates easier, safer and cleaner lives
For more information, please go to www.byotrol.co.uk
This information is provided by RNS
The company news service from the London Stock Exchange
END
ROIURVBRBNAWOAR
(END) Dow Jones Newswires
August 31, 2017 02:00 ET (06:00 GMT)
Byotrol (LSE:BYOT)
Historical Stock Chart
From Apr 2024 to May 2024
Byotrol (LSE:BYOT)
Historical Stock Chart
From May 2023 to May 2024